New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report

Scand J Rheumatol. 2020 Jan;49(1):75-76. doi: 10.1080/03009742.2019.1594359. Epub 2019 Jul 2.

Authors

D Currado¹, Dpe Margiotta¹, C Conforti², R Coppola^{3

4}, V Panasiti⁴, A Afeltra¹, L Navarini¹

Affiliations

¹ Unit of Allergology, Immunology, Rheumatology, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.
² Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.
³ Unit of Plastic and Reconstructive Surgery, Sapienza University, Rome, Italy.
⁴ Unit of Plastic and Reconstructive Surgery, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.

PMID: 31262212
DOI: 10.1080/03009742.2019.1594359

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage
Antibodies, Monoclonal, Humanized / adverse effects*
Dermoscopy
Female
Humans
Injections, Subcutaneous
Middle Aged
Psoriasis / chemically induced*
Psoriasis / diagnosis
Skin / pathology
Spondylitis, Ankylosing / drug therapy*

Substances

Antibodies, Monoclonal, Humanized
secukinumab